TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer reacts to Celgene's (CELG - Get Report) plans to acquire Juno Therapeutics (JUNO for about $9 billion on Monday.

Want more exclusive investing insight from Jim Cramer? Get 24/7 access to Jim's charitable trust portfolio with a free trial to Action Alerts PLUS!

 

Watch all of Jim Cramer's full NYSE live shows right here: